During the past decade, Mass Heart and Rhythm conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mass Heart and Rhythm" are "CRT-D Cardiac Resynchronization Therapy Defibrillator" (1 trials), "Cardiac Resynchronization Therapy" (1 trials), "Cardiovascular Disease" (1 trials), "Defibrillators, Implantable" (1 trials) and "Heart Disease" (1 trials). Many other conditions were trialed in "Mass Heart and Rhythm" in a lesser frequency.

Most popular intervention types in "Mass Heart and Rhythm" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Arm 1 (ATP+Shock)" (1 trials), "Arm 2 (shock only)" (1 trials) and "HeartLogic Sensors" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mass Heart and Rhythm" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Mass Heart and Rhythm". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mass Heart and Rhythm, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mass Heart and Rhythm, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".